bioRxivBioengineeringPreprint
Personalised prediction of anomalous bone regeneration in multiple myeloma patients
Fiona Gibson, Rebecca E. AndrewsiD, Michelle Anne LawsoniD, Andrew ChantryiD, Margaret PaggiosiiD, Catherine HandforthiD, Janet Elizabeth BrowniD, Prash Thayaparan, Sean MolloyiD, Julia C. SheltoniD, Xinshan LiiD, Enrico Dall’AraiD, Stefaan W. VerbruggeniD
Abstract
Recent advances in immunotherapies have dramatically extended the lives of patients with multiple myeloma, resulting in a growing population of elderly patients suffering from damage to their vertebrae caused by this blood cancer. Clinicians typically intervene to fill in these lytic lesions in an attempt to reduce the risk of vertebral collapse and spinal cord injury, however observations of rapid bone regeneration post-cancer treatment suggest that surgery may not always be required. Here we develop a series of mechanistic computational models, optimised using cohorts of healthy volunteer and patient data, to show that vertebrae of recovering multiple myeloma patients rapidly strengthen in a manner not entirely explained by known bone remodelling mechanisms. Furthermore, using pathways informed by genomics data and patient-specific bone biomarkers, we demonstrate the potential for these models to provide personalised predictions of bone disease trajectory.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous proteasome inhibitor resistant disease
R. T. Bishop, A. K. Miller, … D. Basanta·bioRxiv·Nov 13, 2022
- Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy
Jonathan Rodriguez, Abdon Iniguez, … Richard A. Van Etten·eLifePeer-reviewed·Apr 28, 2023
- Bone morphogenetic protein 4 gene therapy in mice inhibits myeloma tumor growth, but has a negative impact on bone
M. Westhrin, T. Holien, … T. Standal·bioRxiv·Mar 13, 2019
- Metastatic infiltration of nervous tissue and periosteal nerve sprouting in multiple myeloma induced bone pain
Marta Diaz‐delCastillo, Oana Palasca, … Anne‐Marie Heegaard·bioRxiv·Dec 29, 2022
- Towards Quantitative Imaging Biomarkers of Tumor Dissemination: a Multi-scale Parametric Modeling of Multiple Myeloma
Marie Piraud, Markus Wennmann, … Bjoern H. Menze·Medical Image AnalysisPeer-reviewed·Jul 4, 2019
- Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy
R. Lutz, F. Gruenschlaeger, … S. Haas·bioRxiv·May 27, 2023